Goal Attainment in Patients with Type 2 Diabetes, Part 2
Jocelyn D. Jones, PharmD, BCPS, Linh B. ter Riet, PharmD, BCPS, Chenise Andrews, PharmD, Mekia Powell, PharmD, Laronne Williams, PharmD, and Frank S. Emanuel, PharmD
Dr. Jones is an assistant professor of pharmacy practice in the College of Pharmacy and Pharmaceutical Sciences at Florida A&M University, Jacksonville. Dr. ter Riet is a medical outcomes specialist in the global research and development division at Pfizer Inc, Jacksonville, FL. At the time of this study, Dr. Andrews, Dr. Powell, and Dr. Williams were doctors of pharmacy candidates in the College of Pharmacy and Pharmaceutical Sciences at Florida A&M. Dr. Emanuel is an associate professor of pharmacy practice and the director of the Jacksonville practice division at Florida A&M. He is also a fellow of the American Society of Health System Pharmacists.
Are patients at a military treatment facility being screened often enough and being treated appropriately according to their disease progression?